Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline’s Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

2026-03-26 - 12:40

Preclinical findings show cytisinicline's minimal 5-HT3 serotonin receptor binding offers insight into observed low nausea rates in smoking and vaping cessation trials Read More